Pooled analysis of the CONFIRM registries: Outcomes in renal disease patients treated for peripheral arterial disease using orbital atherectomy

Journal of Invasive Cardiology

Volumn 26, Issue 8, 2014, Pages 350-354

  Lee, Michael S ^a   Yang, Tae ^b   Adams, George L ^c   Mustapha, Jihad ^d   Das, Tony ^e  

^a UCLA MEDICAL CENTER   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^d Metro Heart and Vascular   (United States)

^e Cardiology and Interventional Vascular Associates   (United States)

Author keywords

atherectomy; peripheral interventions; peripheral vascular disease

Indexed keywords

AGED; ARTICLE; ATHERECTOMY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE REGISTRY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE COMPLICATION; PREVALENCE; TREATMENT OUTCOME; ADVERSE EFFECTS; CLINICAL TRIAL; COMORBIDITY; COMPLICATION; INTRAOPERATIVE COMPLICATIONS; KIDNEY FAILURE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; POSTOPERATIVE COMPLICATIONS; PROCEDURES; REGISTER; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATHERECTOMY; COMORBIDITY; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RENAL INSUFFICIENCY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

EID: 84905491794     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Port FK. Morbidity and mortality in dialysis patients. Kidney Int. 1994;46(6):1728-1737.
2. Luksha N, Luksha L, Carrero JJ, Hammarqvist F, Stenvinkel P, Kublickiene K. Impaired resistance artery function in patients with end-stage renal disease. Clin Sci (Lond). 2011;120(12):525-536.
3. Rajagopalan S, Dellegrottaglie S, Furniss AL, et al. Peripheral arterial disease in patients with end-stage renal disease: Observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Circulation. 2006;114(18):1914- 1922.
4. O'Hare A, Johansen K. Lower-extremity peripheral arterial disease among patients with endstage renal disease. J Am Soc Nephrol. 2001;12(12):2838-2847.
5. Parikh PB, Jeremias A, Naidu SS, et al. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2012;80(3):352-357.
6. Jeremias A, Gruberg L, Patel J, Connors G, Brown DL. Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol. 2010;105(9):1268- 1271.
7. Graziani L, Silvestro A, Bertone V, et al. Percutaneous transluminal angioplasty is feasible and effective in patients on chronic dialysis with severe peripheral artery disease. Nephrol Dial Transplant. 2007;22(4):1144-1149.
8. Kawarada O, Fujihara M, Higashimori A, Yokoi Y, Honda Y, Fitzgerald PJ. Predictors of adverse clinical outcomes after successful infrapopliteal intervention. Catheter Cardiovasc Interv. 2012;80(5):861-871.
9. Kakkos SK, Haurani MJ, Shepard AD, et al. Patterns and outcomes of aortofemoral bypass grafting in the era of endovascular interventions. Eur J Vasc Endovasc Surg. 2011;42(5):658-666.
10. Meltzer AJ, Graham A, Connolly PH, et al. Risk factors for early failure after peripheral endovascular intervention: Application of a reliability engineering approach. Ann Vasc Surg. 2013;27(1):53-61.
11. Abbas AE, Goodman LM, Timmis R, Boura J. Predictors of poor outcome in female patients undergoing endovascular intervention. J Interv Cardiol. 2010;23(4):401-410.
12. Adams GL, Khanna PK, Staniloae CS, Abraham JP, Sparrow EM. Optimal techniques with the Diamondback 360° System achieve effective results for the treatment of peripheral arterial disease. J Cardiovasc Transl Res. 2011;4(2):220-229.
13. Heuser RR. Treatment of lower extremity vascular disease: The Diamondback 360° Orbital Atherectomy System. Expert Rev Med Devices. 2008;5(3):279-286.
14. Das T, Mustapha J, Indes J, et al. Technique optimization of orbital atherectomy in calcified peripheral lesions of the lower extremities: The CONFIRM series, a prospective multicenter registry. Catheter Cardiovasc Interv. 2014;83(1):115-122.
15. Morris ST, McMurray JJ, Spiers A, Jardine AG. Impaired endothelial function in isolated human uremic resistance arteries. Kidney Int. 2001;60(3):1077-1082.
16. Bagi Z, Hamar P, Antus B, Rosivall L, Koller A. Chronic renal failure leads to reduced flowdependent dilation in isolated rat skeletal muscle arterioles due to lack of NO mediation. Kidney Blood Press Res. 2003;26(1):19-26.
17. Jug B, Kadakia J, Gupta M, et al. Coronary calcifications and plaque characteristics in patients with end-stage renal disease: A computed tomographic study. Coron Artery Dis. 2013;24(6):501-508.
18. Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation. 1992;86(1):64-70.
19. Safian RD, Niazi K, Runyon JP, et al; for the OASIS Investigators. Orbital atherectomy for infrapopliteal disease: Device concept and outcome data for the OASIS trial. Catheter Cardiovasc Interv. 2009;73(3):406-412.
20. Shammas NW, Lam R, Mustapha J, et al. Comparison of orbital atherectomy plus balloon angioplasty vs. balloon angioplasty alone in patients with critical limb ischemia: Results of the CALCIUM 360 randomized pilot trial. J Endovasc Ther. 2012;19(4):480-488.